Join to view full profile
3303 S Bond AvePortland, OR 97239
Phone+1 503-494-6594
Fax+1 503-494-5385
Dr. Efstathiou is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of AthensClass of 1998
Certifications & Licensure
OR State Medical License 2026 - 2026
TX State Medical License 2019 - 2025
OK State Medical License 2020 - 2021
Clinical Trials
- Study of the Effect of Chemotherapy With Cabazitaxel on Prostate Cancer Start of enrollment: 2015 Oct 29
- Apalutamide and Gonadotropin-Releasing Hormone Analog With or Without Abiraterone Acetate in Treating Participants With Prostate Cancer Start of enrollment: 2017 Oct 13
- Apalutamide, Abiraterone Acetate, and Prednisone in Treating Participants With Metastatic Castration Resistant Prostate Cancer Start of enrollment: 2018 Mar 06
Publications & Presentations
PubMed
- Perioperative Apalutamide in High-Risk Localized Prostate Cancer.Mary-Ellen Taplin, Martin Gleave, Neal D Shore, Angela Lopez-Gitlitz, Alexander Kretschmer
The New England Journal of Medicine. 2026-08-06 - 1 citationsA multi-modal approach for decision making in bladder cancer.Hasan Al-Sattar, Hao Ding, Oluchi Okoli, Somto Okoli, Aruni Ghose
Nature Reviews. Urology. 2026-07-01 - 1 citationsBarriers and solutions for healthcare professionals to involve patients as partners in oncology research: Project RISE.Eamonn T Rogers, Thomas G Bognanno, Thomas Perkins, Brittany Wolf Gianares, Kristine W Schuler
Future Oncology. 2026-02-01
Authored Content
- M0 CPRC: Overview of Treatment Options APCCC 2022 Presentation Eleni EfstathiouAugust 2022
Press Mentions
Janux Announces Encouraging Efficacy and Safety Profile from Ongoing Phase 1 Clinical Trial for JANX007 in mCRPCDecember 1st, 2025
Niraparib and Abiraterone Combination Is Beneficial in Prostate CancerMarch 20th, 2023
Latest in Hormone Sensitive Prostate CancerFebruary 18th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:










